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Abstract 
 
The aim of the present study is to investigate possible impact of EGFP on the 
resistance of cancer cells to platinum-based drugs (cisplatin, carboplatin and oxaliplatin). The 
work follows on our previous study with BCRP efflux transporter, which suggested that 
higher resistance of cancer cells to platinum-based drugs is caused rather by the presence of 
EGFP than by the efflux transporter. To confirm this hypothesis series of cytotoxic MTT tests 
were performed on human Hep2 parent cell line and Hep2-EGFP cell line transfected for the 
expression of EGFP. Our results demonstrated higher tolerance of transfected Hep2-EGFP 
cells to platinum-based drugs compared with the parent Hep2 cell lines. Based on the obtained 
results we conclude that EGFP interferes with the toxicity of platinum-based drugs, which can 
cause misinterpretation of results obtained in the cytotoxicity studies. 
 
